FDA Modernization Act of 2021
Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act to allow manufacturers and sponsors of a drug to use alternative testing methods to animal testing to … Show full official titleShow less
Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act to allow manufacturers and sponsors of a drug to use alternative testing methods to animal testing to investigate the safety and effectiveness of a drug, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
FDA Modernization Act of 2021
This bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug's safety and effectiveness. Under this bill, these alternative methods may include cell-based assays, organ chips and microphysiological systems, computer modeling, and other human biology-based test methods.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2952: FDA Modernization Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-S-2952/
"S. 2952: FDA Modernization Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-2952/.
S. 2952, 117th Cong. (2026), https://openamerica.io/bill/117-S-2952/.
[S. 2952: FDA Modernization Act of 2021](https://openamerica.io/bill/117-S-2952/)